IMPROVED METHOD OF ISOLATION AND GROWTH OF H PYLORI

Information

  • Research Project
  • 2642948
  • ApplicationId
    2642948
  • Core Project Number
    R41CA075674
  • Full Project Number
    1R41CA075674-01A1
  • Serial Number
    75674
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1998 - 26 years ago
  • Project End Date
    5/31/1999 - 25 years ago
  • Program Officer Name
    HALL, LEOTA
  • Budget Start Date
    6/1/1998 - 26 years ago
  • Budget End Date
    5/31/1999 - 25 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    5/28/1998 - 26 years ago

IMPROVED METHOD OF ISOLATION AND GROWTH OF H PYLORI

DESCRIPTION (Adapted from the applicant's abstract): H. pylori causes >90% of the cases of gastritis, peptic ulcer and stomach cancer. Current diagnostic methods are far from optimal: serologic tests cannot indicate whether H. pylori has been eradicated or determine bacterial antibiotic resistance and therefore, cannot monitor efficacy of treatment or recrudescence; breath tests for urea require expensive and specialized equipment and reagents; and the identification of H. pylori in gastric biopsies, the diagnostic "gold standard" is compromised by the difficulties of culturing the bacterium. The investigators have found that certain fluorocarbons enhance the ability to culture H. pylori on agar plates, apparently by aiding the maintenance of HP in the spiral (pathogenic) culturable form and preventing their conversion to the dormant coccoid form. Thus, the agar-fluorocarbon interface may mimic the gastric environment and provide an improved environment for HP growth. They propose to evaluate the utility of fluorocarbons in enabling the reproducible culture of this pathogen from human gastric biopsies and, possibly, from stool of infected patients. A successful outcome of this research to develop improved culture methodology would greatly facilitate diagnosis of HP infections in clinical microbiology laboratories as well as the study of the pathogenesis of Helicobacter- associated gastric disease. PROPOSED COMMERCIAL APPLICATION: The intended applications, should the research prove fruitful, are use of fluorocarbons as additives to commercially available culture packs for microaerophilic microbes. This would enable H. pylori to be culture reproducibly for clinical diagnostic use.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R41
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG5
  • Study Section Name
  • Organization Name
    ALLIANCE PHARMACEUTICAL CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921212729
  • Organization District
    UNITED STATES